HUP0301766A2 - Latens antitrombin III előállítása - Google Patents

Latens antitrombin III előállítása

Info

Publication number
HUP0301766A2
HUP0301766A2 HU0301766A HUP0301766A HUP0301766A2 HU P0301766 A2 HUP0301766 A2 HU P0301766A2 HU 0301766 A HU0301766 A HU 0301766A HU P0301766 A HUP0301766 A HU P0301766A HU P0301766 A2 HUP0301766 A2 HU P0301766A2
Authority
HU
Hungary
Prior art keywords
antithrombin iii
preparation
latent
latent antithrombin
incubating
Prior art date
Application number
HU0301766A
Other languages
English (en)
Inventor
Göran Karlsson
Original Assignee
Octapharma Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0004086A external-priority patent/SE0004086D0/xx
Application filed by Octapharma Ag. filed Critical Octapharma Ag.
Publication of HUP0301766A2 publication Critical patent/HUP0301766A2/hu
Publication of HUP0301766A3 publication Critical patent/HUP0301766A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Eljárás latens antitrombin III előállítására, azzal jellemezve, hogy anatív antitrombin III-at szulfátionokat és Good-féle ikerionospufferekből választott puffert tartalmazó oldatban inkubálják. Ó
HU0301766A 2000-11-08 2001-11-08 Process for the preparation of latent antithrombin iii HUP0301766A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0004086A SE0004086D0 (sv) 2000-11-08 2000-11-08 Preparation process
US25214800P 2000-11-20 2000-11-20
PCT/SE2001/002473 WO2002038610A1 (en) 2000-11-08 2001-11-08 Process for the preparation of latent antithrombin iii

Publications (2)

Publication Number Publication Date
HUP0301766A2 true HUP0301766A2 (hu) 2003-08-28
HUP0301766A3 HUP0301766A3 (en) 2005-12-28

Family

ID=26655296

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301766A HUP0301766A3 (en) 2000-11-08 2001-11-08 Process for the preparation of latent antithrombin iii

Country Status (15)

Country Link
EP (1) EP1332159A1 (hu)
JP (1) JP2004522707A (hu)
KR (1) KR20030057545A (hu)
AU (1) AU2002214468A1 (hu)
BR (1) BR0115188A (hu)
CA (1) CA2428055A1 (hu)
CZ (1) CZ20031277A3 (hu)
EE (1) EE200300218A (hu)
HU (1) HUP0301766A3 (hu)
IL (1) IL155539A0 (hu)
MX (1) MXPA03004030A (hu)
NO (1) NO20032048D0 (hu)
PL (1) PL360410A1 (hu)
RU (1) RU2003117016A (hu)
WO (1) WO2002038610A1 (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
SE0203770D0 (sv) * 2002-12-19 2002-12-19 Biovitrum Ab Method of separation
PL1848473T3 (pl) 2005-02-07 2013-11-29 Hanuman Llc Urządzenie - koncentrator osocza
US7694828B2 (en) 2005-04-27 2010-04-13 Biomet Manufacturing Corp. Method and apparatus for producing autologous clotting components
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
US7806276B2 (en) 2007-04-12 2010-10-05 Hanuman, Llc Buoy suspension fractionation system
EP2567692B1 (en) 2008-02-27 2016-04-06 Biomet Biologics, LLC Use of a device for obtaining interleukin-1 receptor antagonist rich solutions
US8337711B2 (en) 2008-02-29 2012-12-25 Biomet Biologics, Llc System and process for separating a material
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US9550028B2 (en) 2014-05-06 2017-01-24 Biomet Biologics, LLC. Single step desiccating bead-in-syringe concentrating device

Also Published As

Publication number Publication date
RU2003117016A (ru) 2004-12-10
EP1332159A1 (en) 2003-08-06
NO20032048L (no) 2003-05-07
MXPA03004030A (es) 2004-02-12
PL360410A1 (en) 2004-09-06
KR20030057545A (ko) 2003-07-04
EE200300218A (et) 2003-08-15
AU2002214468A1 (en) 2002-05-21
HUP0301766A3 (en) 2005-12-28
IL155539A0 (en) 2003-11-23
JP2004522707A (ja) 2004-07-29
NO20032048D0 (no) 2003-05-07
CZ20031277A3 (cs) 2003-08-13
BR0115188A (pt) 2004-02-03
CA2428055A1 (en) 2002-05-16
WO2002038610A1 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
HUP0301766A2 (hu) Latens antitrombin III előállítása
HUP0302364A3 (en) Novel cyclodextrin glucanotransferase, process for producing the same and process for producing cyclodextrin by using this enzyme
ATE294031T1 (de) Reinigungsverfahren welches ultraschallwellen verwendet
BR0009480A (pt) Soluções de poliuretano com unidades de estrutura de alcoxissilano
ATE318189T1 (de) Reinigungsverfahren welches ultraschallwellen verwendet
ES2192085T3 (es) Terminal de autoservicio.
AU2002218932A1 (en) Process for producing potassium sulfate from sodium sulfate
HUP0401583A2 (hu) Látens savanyítószert tartalmazó toalett szappan
JO2243B1 (en) Prepare a 6.3-dicyl-6.5-dihydro-4 hydroxy-pyran-2-one compound
JO2249B1 (en) A compound of 6.3-dialkyl-6.5-dihydro-4-hydroxy-biran-2-one
EP1544291A4 (en) A NEW METHOD FOR THE PRODUCTION OF ANTIBODY CYME, NEW ANTIBODY CYM AND USE THEREOF
AU2001281250A1 (en) (hydroxyethyl)ureas as inhibitors of alzheimer's beta-amyloid production
ITRM20000266A0 (it) Procedimento migliorato per la preparazione di (e,z) 3-(2-amminoetossimmino)-androstano-6, 17-dione e di suoi analoghi.
NO975413L (no) Koboltmetallagglomerater, samt fremgangsmåte for fremstilling og anvendelse derav
MXPA02001406A (es) Heterociclilos-2h-cromenos substituidos.
PL366988A1 (en) Gelling sugar and method for producing the same
SE0002835D0 (sv) Method and kit for production of monoclonal antibodies
FR2815332B1 (fr) Devidoir suspendu, notamment pour cultures
MXPA02003042A (es) Proceso para prevenir formacion de incrustaciones.
MXPA04004526A (es) N-metil-homocisteinas, su uso y metodo para su produccion.
SE9800865D0 (sv) New Process
ATE242763T1 (de) Methoximinophenylessigsäureamide
SE0004086D0 (sv) Preparation process
TR200003084T2 (tr) Paroxetine askorbat
MXPA02012788A (es) Metodo para la preparacion de pantotenato de calcio.

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees